User profiles for Priya Abraham
Priya AbrahamChristian Medical College, National Institute of Virology Verified email at cmcvellore.ac.in Cited by 8817 |
[HTML][HTML] Transmission electron microscopy imaging of SARS-CoV-2
242 INDIAN J MED RES, FEBRUARY & MARCH 2020 the mature virion and complete
surface glycoprotein organization. A recent cryoEM study imaging the purified envelope spike …
surface glycoprotein organization. A recent cryoEM study imaging the purified envelope spike …
[HTML][HTML] Full-genome sequences of the first two SARS-CoV-2 viruses from India
Methods: Throat swab/nasal swab specimens for a total of 881 suspected cases were
screened by E gene and confirmed by RdRp (1), RdRp (2) and N gene real-time reverse …
screened by E gene and confirmed by RdRp (1), RdRp (2) and N gene real-time reverse …
Hepatitis E superinfection produces severe decompensation in patients with chronic liver disease
Background and Aims: The adverse effect of acute hepatitis A in chronic liver disease is well
known. The outcome of acute hepatitis E in chronic liver disease has not been extensively …
known. The outcome of acute hepatitis E in chronic liver disease has not been extensively …
Temperature-dependent spectroscopic evidences of curcumin in aqueous medium: a mechanistic study of its solubility and stability
R Jagannathan, PM Abraham… - The Journal of Physical …, 2012 - ACS Publications
In curcumin, keto–enol–enolate equilibrium of the heptadiene-dione moiety determines its
physiochemical and antioxidant properties. However, its poor solubility in water at neutral pH …
physiochemical and antioxidant properties. However, its poor solubility in water at neutral pH …
In situ synthesis and surface functionalization of gold nanoparticles with curcumin and their antioxidant properties: an experimental and density functional theory …
…, R Jagannathan, P Khandelwal, PM Abraham… - Nanoscale, 2013 - pubs.rsc.org
Curcumin ((1E,6E)-1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) is an
active component of turmeric; it is responsible for its characteristic yellow color and therapeutic …
active component of turmeric; it is responsible for its characteristic yellow color and therapeutic …
[HTML][HTML] Perspectives for repurposing drugs for the coronavirus disease 2019
The newly emerged 2019 novel coronavirus (CoV), named as severe acute respiratory
syndrome CoV-2 (SARS-CoV-2), like SARS-CoV (now, SARS-CoV-1) and Middle East …
syndrome CoV-2 (SARS-CoV-2), like SARS-CoV (now, SARS-CoV-1) and Middle East …
[HTML][HTML] SARS-CoV-2 spike mutations, L452R, T478K, E484Q and P681R, in the second wave of COVID-19 in Maharashtra, India
As the global severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic
expands, genomic epidemiology and whole genome sequencing are being used to investigate …
expands, genomic epidemiology and whole genome sequencing are being used to investigate …
Genomic characterization and epidemiology of an emerging SARS-CoV-2 variant in Delhi, India
…, RS Mani, G Arunachal Udupi, P Abraham… - Science, 2021 - science.org
Delhi, the national capital of India, experienced multiple severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) outbreaks in 2020 and reached population seropositivity of >50…
coronavirus 2 (SARS-CoV-2) outbreaks in 2020 and reached population seropositivity of >50…
[HTML][HTML] Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial
Background To mitigate the effects of COVID-19, a vaccine is urgently needed. BBV152 is a
whole-virion inactivated SARS-CoV-2 vaccine formulated with a toll-like receptor 7/8 agonist …
whole-virion inactivated SARS-CoV-2 vaccine formulated with a toll-like receptor 7/8 agonist …
Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial
Background We report the clinical efficacy against COVID-19 infection of BBV152, a whole
virion inactivated SARS-CoV-2 vaccine formulated with a toll-like receptor 7/8 agonist …
virion inactivated SARS-CoV-2 vaccine formulated with a toll-like receptor 7/8 agonist …